{"product_id":"cleveland-clinic-nephrology-update-2025","title":"Cleveland Clinic Nephrology Update 2025","description":"\u003ch3\u003eCleveland Clinic Nephrology Update 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 12 videos + 34 pdfs, size: 8 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: nephrologists, rheumatologists, internists, maternal fetal medicine providers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eCleveland Clinic Nephrology Update 2025\u003c\/strong\u003e. This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. \u003cstrong\u003eCleveland Clinic Nephrology Update 2025\u003c\/strong\u003e features experts that will address diagnosis and management strategies for patients with kidney disease.\u003cbr\u003e\u003ch3\u003eBy Attending, You Will Be Able To:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe and critically appraise recent advancements in chronic kidney disease management, including the integration of novel pharmacotherapies such as SGLT2 inhibitors, GLP-receptor agonists, and non-steroidal MRAs into treatment plans.\u003c\/li\u003e\n\u003cli\u003eDiscuss the management of various complications in CKD and ESKD.\u003c\/li\u003e\n\u003cli\u003eDiscuss obesity in CKD and the role of nephrology providers.\u003c\/li\u003e\n\u003cli\u003eEvaluate the latest evidence-based treatment strategies for IgA nephropathy and lupus nephritis, with a focus on novel therapies.\u003c\/li\u003e\n\u003cli\u003eAnalyze the role of complement activation in various kidney diseases and explore the role of novel therapeutic interventions targeting the complement system.\u003c\/li\u003e\n\u003cli\u003eHighlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapeutics.\u003c\/li\u003e\n\u003cli\u003eReview the basics of dialysis vascular access and critically appraise recent advances in the field.\u003c\/li\u003e\n\u003cli\u003eAssess the unique challenges of managing kidney disease in pregnant patients, including hypertension, preeclampsia, and acute kidney injury, with a focus on balancing maternal and fetal health.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho Should Attend?\u003c\/h3\u003e\u003cbr\u003eThis activity is designed for nephrologists, rheumatologists, internists, maternal fetal medicine providers, nurses, nurse practitioners, physician assistants, and other practicing health care professionals who desire an update on recent advancements in chronic kidney disease management, treatment strategies for IgA nephropathy and lupus nephritis, managing kidney-related complications in cancer patients, and the unique challenges of managing kidney disease in pregnant patients.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003cbr\u003eSession I Updates and Challenges in CKD Care (Part 1) Anticoagulation in CKD and ESKD.pdf\u003cbr\u003eSession I Updates and Challenges in CKD Care (Part 1) Calciphylaxis and Skin Issues in CKD.pdf\u003cbr\u003eSession I Updates and Challenges in CKD Care (Part 1) CKD KDIGO Guidelines Update.pdf\u003cbr\u003eSession I Updates and Challenges in CKD Care (Part 1).mp4\u003cbr\u003eSession II Updates and Challenges in CKD Care (Part 2) Hypertension Management in CKD.pdf\u003cbr\u003eSession II Updates and Challenges in CKD Care (Part 2) Nutrition and CKD.pdf\u003cbr\u003eSession II Updates and Challenges in CKD Care (Part 2) Obesity and CKD.pdf\u003cbr\u003eSession II Updates and Challenges in CKD Care (Part 2).mp4\u003cbr\u003eSession III Vascular Access Symposium- An Update for the Nephrologist 1.pdf\u003cbr\u003eSession III Vascular Access Symposium- An Update for the Nephrologist 2.pdf\u003cbr\u003eSession III Vascular Access Symposium- An Update for the Nephrologist 3.pdf\u003cbr\u003eSession III Vascular Access Symposium.mp4\u003cbr\u003eSession IV Journal Club 1.pdf\u003cbr\u003eSession IV Journal Club 2.pdf\u003cbr\u003eSession IV Journal Club.mp4\u003cbr\u003eSession V Updates in Glomerular Diseases (Part 1) Genetics in Primary Nephrotic Syndrome.pdf\u003cbr\u003eSession V Updates in Glomerular Diseases (Part 1) Kidney Success- Clinical Trials in Nephrology.pdf\u003cbr\u003eSession V Updates in Glomerular Diseases (Part 1) Update in Primary Nephrotic Syndrome.pdf\u003cbr\u003eSession V Updates in Glomerular Diseases (Part 1).mp4\u003cbr\u003eSession VI Updates in Glomerular Diseases (Part 2) CAR-T for Autoimmune diseases.pdf\u003cbr\u003eSession VI Updates in Glomerular Diseases (Part 2) IgA Nephropathy Update.pdf\u003cbr\u003eSession VI Updates in Glomerular Diseases (Part 2) Lupus Nephritis Update.pdf\u003cbr\u003eSession VI Updates in Glomerular Diseases (Part 2).mp4\u003cbr\u003eSession VII Kasperzak Lecture and Case Discussions Clinicopathologic Case Discussions.pdf\u003cbr\u003eSession VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 1.pdf\u003cbr\u003eSession VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 2.pdf\u003cbr\u003eSession VII Kasperzak Lecture and Case Discussions.mp4\u003cbr\u003eSession VIII Vasculitis Update and Case Discussions Clinicopathologic Case Discussions.pdf\u003cbr\u003eSession VIII Vasculitis Update and Case Discussions Vasculitis Mimics.pdf\u003cbr\u003eSession VIII Vasculitis Update and Case Discussions What’s New in Vasculitis.pdf\u003cbr\u003eSession VIII Vasculitis Update and Case Discussions.mp4\u003cbr\u003eSession IX Update in Onco-nephrology Case Discussions in Onconephrology.pdf\u003cbr\u003eSession IX Update in Onco-nephrology Immunotherapy and the Kidneys.pdf\u003cbr\u003eSession IX Update in Onco-nephrology TKI and VEGF Inhibitors.pdf\u003cbr\u003eSession IX Update in Onco-nephrology.mp4\u003cbr\u003eSession X Monoclonal Gammopathy of Renal Significance (MGRS) A Primer into MGRS- What a Nephrologist Should Know.pdf\u003cbr\u003eSession X Monoclonal Gammopathy of Renal Significance (MGRS) Case Discussions in MGRS.pdf\u003cbr\u003eSession X Monoclonal Gammopathy of Renal Significance (MGRS).mp4\u003cbr\u003eSession XI Obstetric Nephrology AKI in Pregnancy.pdf\u003cbr\u003eSession XI Obstetric Nephrology Case Discussions in Obstetric Nephrology.pdf\u003cbr\u003eSession XI Obstetric Nephrology GN in Pregnancy CKD Pregnancy Counseling.pdf\u003cbr\u003eSession XI Obstetric Nephrology.mp4\u003cbr\u003eSession XII Updates in the World of Kidney Transplantation Medical Updates in Kidney Transplant.pdf\u003cbr\u003eSession XII Updates in the World of Kidney Transplantation Surgical Updates in Kidney Transplant.pdf\u003cbr\u003eSession XII Updates in the World of Kidney Transplantation.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954488053858,"sku":"MED-AMB04370","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cleveland-Clinic-Nephrology-Update-2025.png?v=1779377783","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-nephrology-update-2025","provider":"Meducourse","version":"1.0","type":"link"}